DMOG increases BMDAC viability by decreasing apoptosis and increasing proliferation. (A) Equal numbers of BMDACs were cultured in endothelial growth media in the presence of vehicle or DMOG for 4 days, and viable cells were counted using the Trypan blue exclusion method. *P < .001, DMOG vs vehicle. #P < .001 vs time 0; Bonferroni post hoc test after 2-way ANOVA. The overall effects of time and DMOG treatment on BMDAC survival were significant (P < .001). (B) Apoptosis was detected at day 4 as phycoerythrin-conjugated annexin V (annexin V-PE) positive/7-amino-actinomycin D (7-AAD) negative cells (green rectangle) using flow cytometry. (C) Cell cycle distribution of BMDACs stained with propidium iodide and analyzed by flow cytometry. Data are mean ± SEM (n = 3 or 4).